In this episode of the OIS Podcast, host Rob Rothman sits down with Jay Cormier, CEO of Eyedaptic, to explore innovative solutions for individuals with vision loss. They discuss Eyedaptic's groundbreaking technology and its impact on enhancing daily life for those with visual impairments.

Key Highlights:

• Insight into the inspiration behind Eyedaptic and its mission to improve independence for the visually impaired.
• Overview of the EYE5 product, an augmented reality solution that enhances mobility and connection to the environment.
• Discussion on the recent launch of Ivy, an AI visual assistant that transforms user interaction with their surroundings.
• Importance of targeted marketing and in-person demos for increasing accessibility to Eyedaptic’s products.

Join us to discover how Eyedaptic is revolutionizing the way we think about vision care!

In this week’s OIS Podcast episode, Host Dr. Robert Rothman sits down with Almog Aley-Raz, CEO of CorNeat Vision, for a fascinating discussion. They cover:

• Almog’s career journey from Israel to the U.S.
• How a mountain biking trip with an ophthalmologist sparked the idea for CorNeat Vision
• Corneal blindness as a global issue and the need for better solutions, especially in regions with limited donor tissue and trained surgeons
• CorNeat's groundbreaking synthetic cornea, made with their unique material, Avatrix, which offers exciting potential for restoring vision
• Applications of Avatrix beyond ophthalmology, including maxillofacial and dental procedures

Tune in now to learn more!

Exciting insights from the OIS Retina Panel! Moderated by Dr. Emmett Cunningham, this discussion dives deep into the current state of ophthalmology investment and innovation. Panelists, Anna Chen, Adit Ghosh, Dr. Firas Rahhal and Caroline Stout shared their perspectives on the evolving landscape, highlighting both opportunities and challenges in the field.

Here are the key takeaways:

• Cautious Optimism: A resurgence in private markets, but drug development challenges persist.
• Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.
• Strategic Partnerships: Crucial for commercialization in ophthalmology.
• Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.
• Market Concerns: Uncertainties around gene therapy and commercial viability.

Don’t miss out—listen in now to gain valuable insights!

Don’t miss the OIS Retina Panel, moderated by Dr. Pravin Dugel, “The View from the Street.” Join Dr. Anupam Dalal, Andrew Gitkin, and Cameron Taylor as they discuss the latest in ophthalmology, including:

• Current Challenges: Few blockbuster drugs and limited M&A activity
• Opportunities: Growth potential from recent GA therapy successes
• Strategic Insights: Importance of community and networking

Get valuable insights from industry experts and stay ahead of the curve. Listen in now!

Discover the milestone 400th episode of the OIS podcast with Dr. Firas Rahhal and Dr. Robert Rothman, where they explore the impact of Ophthalmology Innovation Summit (OIS) on the investment ecosystem:

• Journey of OIS
• Rich Insights
• Collaboration
• Clinical Mastery
• Long-Term Relationships
• Humor and Admiration
• Future of Ophthalmology

Tune in to this episode for a blend of knowledge, inspiration, and laughter as they navigate the future of eye care innovation. Don’t miss out—listen now!

In this episode of Eye on Innovation Podcast, Carey Powers delves into the latest advancements in corneal crosslinking technology with expert guest Dr. Deepinder Dhaliwal. Dr. Dhaliwal, a renowned professor of ophthalmology at the University of Pittsburgh School of Medicine and director of refractive surgery at the UPMC Vision Institute, shares her extensive knowledge and insights. Here’s what you can expect:

• Prevalence of Keratoconus: Discover how improved diagnostic imaging has revealed a higher prevalence of keratoconus than previously thought, affecting 1.2% of 20-year-olds.
• Current Standard of Care: Learn about the FDA-approved epithelium-off crosslinking procedure and its role in treating progressive keratoconus in the U.S.
• Unmet Needs in Treatment: Understand the challenges of current crosslinking procedures, including patient discomfort, long recovery times, and the need for safer, faster options.
• Innovative Solutions: Get insights into upcoming advancements like epithelium-on crosslinking, which promises quicker recovery and fewer side effects.
• Future Directions: Hear about the potential for custom crosslinking procedures and the exciting work being done in the field to stabilize even very thin corneas.
• Early Detection: Explore the importance of early keratoconus detection through corneal tomography and the potential role of AI in identifying at-risk patients sooner.

Tune in to gain a comprehensive understanding of the latest innovations and future possibilities in corneal crosslinking technology. Don't miss this insightful conversation!

In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:

• Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion Biotech
• The innovative allogenic cell therapy technology developed by Aurion
• How this technology addresses the global shortage of corneal tissue
• Insights into the challenges and breakthroughs in scaling production and securing market approval
• Future applications of cell therapy in ophthalmology beyond corneal endothelial disease

Don't miss this fascinating conversation on the future of medical innovation in ophthalmology! Listen to the episode and subscribe to the OIS Podcast for more updates on the latest trends in eye care and medical technology.

This week's OIS Podcast features a compelling panel discussion from the Dry Horizons Symposium co-presented by Ora and OIS, held on May 3 in Seattle. The panel, comprising leading experts in ophthalmology and dry eye research, covered essential topics in the field:

🔹Advancements in Diagnostics: Insights into new tools and technologies for more accurate and reliable diagnosis of dry eye syndrome.
🔹Regulatory Challenges: Discussion on the regulatory landscape and the hurdles faced in gaining approval for innovative treatments.
🔹Artificial Intelligence in Dry Eye Management: Exploration of AI's potential to transform the management and treatment of dry eye through enhanced diagnostics and personalized care.
🔹The Quest for a Cure: Perspectives on the ongoing research efforts and the journey toward finding a cure for dry eye syndrome.

Tune in to hear the expert opinions and in-depth analysis shared by the panelists, providing a comprehensive overview of the current state and future directions of dry eye research and treatment.

Explore the cutting-edge world of ophthalmology with the Eye on Innovation Podcast. In the latest episode, Carey Powers hosts Dr. Rishi Singh and Dr. Michael Singer as they delve into how AI and robotics are transforming retina medicine, bringing unprecedented changes to diagnosis, clinical trials, and patient care. This insightful discussion provides valuable information for ophthalmologists, researchers, and anyone interested in the future of eye care. Here’s what you can expect from this episode:

• AI in Diagnostics: Learn how AI technology is streamlining and enhancing the accuracy of retina diagnostics through devices like Optical Coherence Tomography (OCT).
• Robotics in Surgery: Discover the challenges and opportunities of integrating robotics into retinal surgery, and what the future might hold for these advanced surgical techniques.
• Improved Clinical Trials: Find out how AI is enabling better patient selection and more efficient clinical trial processes, leading to potentially better outcomes.
• FDA Regulation: Understand the regulatory landscape and what it means for the adoption of AI and robotics in medical devices.

Don't miss this episode if you want to stay ahead in the rapidly evolving field of ophthalmology. Tune in now and be a part of the conversation shaping the future of eye care.

In this compelling OIS podcast episode, host Dr. Rob Rothman engages in an insightful conversation with Dr. Malvina Eydelman, the Director of the FDA's Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices. Delve into Malvina's unique career journey and discover how her diverse background in engineering and ophthalmology has influenced her work at the FDA.

 Here's what you can expect from this episode:

• Malvina's Journey: Learn how Malvina went from growing up in Georgia to becoming a key leader at the FDA, thanks to her strong engineering and medical background.
• FDA's Role in Innovation: Discover how the FDA is evolving to support innovation, with a focus on collaborative workshops and clear standards for ophthalmic devices.
• Leadership During COVID-19: Hear about Malvina's critical role during the COVID-19 pandemic, managing the rapid approval and production of ventilators and respiratory devices.
• Tips for Early Engagement with the FDA: Get valuable advice on how to navigate the FDA's processes and why early communication is crucial for success in medical device development.

This episode is a must-listen for anyone interested in the intersection of healthcare, technology, and regulatory processes. Click the link to listen now!